Skip to content

To study the patient survival outcomes in the elderly Indian chronic kidney disease cohort

Formation of Elderly Indian Chronic Kidney Disease (ELI-CKD) cohort and to study their long term survival outcomes - Not Applicable

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/060323
Enrollment
681
Registered
2023-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

Indian Council of Medical Research
Lead Sponsor
ABVIMS Dr RML Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with CKD stage 3b, 4, and 5 patients defined by KDIGO guidelines attending Nephrology OPD. 2. More than 60 years of age.

Exclusion criteria

Exclusion criteria: 1. Patients who are not willing to participate in the study. 2. Patients suffering from terminal non-renal related illness with an expected life expectancy of fewer than 6 months (investigators clinical judgement). 3. Renal transplant recipients. 4. Patient already receiving maintenance hemodialysis or peritoneal dialysis.

Design outcomes

Primary

MeasureTime frame
1. Renal progression – defined as loss of more than 5 ml/min/1.73 m2 estimated GFR in one year 2. Mortality – Death during study periodTimepoint: 3 months, 6 months and 1 year

Secondary

MeasureTime frame
1. To assess the nutritional status and to correlate with survival, frailty, Quality of Life and cognition. 2. To compare the outcome of conservative care and dialysis in CKD stage 5 cohort requiring RRT.Timepoint: 3 months, 6 months and 1 year

Countries

India

Contacts

Public ContactMuthukumar Balakrishnan

ABVIMS, Dr. RML Hospital

itzmedrmuthu@gmail.com8800735952

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026